Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates For The Next Quarter
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.
Abaxis (NASDAQ: ABAX) is estimated to post earnings of $0.24 per share in the June quarter. Abaxis' trailing-twelve-month revenue is $178.79 million.
Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.22 per share in the June quarter. Meridian Bioscience's trailing-twelve-month operating margin is 29.72%.
SurModics (NASDAQ: SRDX) is likely to earn $0.22 per share in the June quarter. SurModics had $30.96 million in total cash for the latest quarter.
Trinity Biotech plc (NASDAQ: TRIB) may earn $0.20 per share in the March quarter. Trinity Biotech's PEG ratio is 1.88.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.